Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Loss of Tumor Suppressor Gene Functions

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

Loss of Tumor Suppressor Gene Functions

Loss of Tumor Suppressor Gene Functions

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

ICMT supports BRAF<sup>V600E</sup>-driven tumor growth by membrane targeting of the CAAX protein INPP5E.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Overcoming dietary dogmas.

Nature metabolism·2026

Same author

ICMT deficiency ameliorates weight loss and mortality, but not tumor formation in a mouse model of liver cancer.

Cell communication and signaling : CCS·2026

Same author

BRAF inhibition increases TGFβ2 production and stimulates metastasis in mice with endogenous BRAF<sup>V600E</sup>-induced hepatocellular carcinoma.

Proceedings of the National Academy of Sciences of the United States of America·2025

Same author

The liver clock modulates circadian rhythms in white adipose tissue.

Molecular metabolism·2025

Same author

Pyrin inflammasome-driven erosive arthritis caused by unprenylated RHO GTPase signaling.

EMBO molecular medicine·2025

Search research articles

Related Experiment Video

Updated: Mar 17, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

What makes oncogenes mutually exclusive?

Jaroslaw Cisowski¹, Martin O Bergo^1,2

¹a Sahlgrenska Cancer Center, Department of Molecular and Clinical Medicine, Institute of Medicine , University of Gothenburg , Gothenburg , Sweden.

|July 15, 2016

Summary

This summary is machine-generated.

Cancer driver mutations, like KRAS^G12D and BRAF^V600E, are often mutually exclusive. Coexpression in lung cancer triggers oncogene-induced senescence, preventing tumor progression.

Keywords:

RAF RAS mutual exclusivity oncogene senescence

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

Related Experiment Videos

Last Updated: Mar 17, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

Area of Science:

Oncology
Molecular Biology
Genetics

Background:

Cancer arises from mutations in genes controlling cell proliferation and survival.
Accumulating driver mutations is often assumed to accelerate tumor growth.
Large-scale studies reveal mutual exclusivity among driver oncogenes, challenging this assumption.

Purpose of the Study:

To investigate the mechanisms behind the mutual exclusivity of oncogenes.
To explore the specific interaction between KRAS^G12D and BRAF^V600E in lung cancer.
To understand why coexpression of these oncogenes does not lead to faster tumor progression.

Main Methods:

Utilized mouse models of lung cancer.
Studied the effects of coexpressing KRAS^G12D and BRAF^V600E oncogenes.
Analyzed the cellular response to oncogene coexpression.

Main Results:

KRAS^G12D and BRAF^V600E were found to be mutually exclusive in lung cancer mouse models.
Coexpression of KRAS^G12D and BRAF^V600E induced senescence.
This senescence acts as a barrier to tumor progression.

Conclusions:

The mutual exclusivity of KRAS^G12D and BRAF^V600E in lung cancer is driven by oncogene-induced senescence.
This mechanism explains why tumors do not accumulate multiple driver mutations in these pathways.
Findings provide insights into cancer development and potential therapeutic strategies.